Social media

Meet us at AASLD, booth #1041 to learn how our deep expertise in imaging-based hepatic biomarkers and global operational support help sponsors optimise trial design and accelerate the delivery of MASH treatments to patie...

Upstream and downstream process, structural characterisation, functional characterisation and processes are all major CMC related steps that need to be considered by emerging and biotech companies early in their developm...

The FDA and other health authorities like the EMA require a well-defined and consistent drug development process and life cycle management plan. CMC is a critical and a ‘first step’ component in the creation of a develop...

USP compounding may be fast — but is it costing you quality, compliance, and insight? Join our webinar to learn why GMP is the smarter choice for early phase trials. During this session we will discuss: • The differences...

The Asia-Pacific (APAC) region is quickly becoming a key player in the global biosimilars market. Additionally, as the region’s incidence of chronic disease rises, this is driving demand for more cost-effective treatment...

The incidence of chronic disease across APAC is rising. Biosimilars, with their potential to deliver high-quality treatment at lower costs, are well-positioned to meet this need. However, barriers to adoption, both from ...

Pediatric clinical trials have different processes, risks and challenges than adult trials. Identifying those differences is critical but can be difficult, especially if resources are limited. In our on-demand webinar, ...

Clinical development processes for pediatric trials differ from adult trials. Watch our on-demand webinar to learn about regulatory strategies and tools needed to ensure pediatric access to medical treatment and an inter...

Know where every sample is, every step of the way. LabView360 provides real-time visibility, reducing manual errors, and accelerating results. With an intuitive mobile-responsive app, sites can scan barcodes, streamline...

PubsHub Journals & Congresses are indexed by Clarivate Analytics, with updated impact factors and Journal Citation Reports (JRC) categories annually. Use the information to pick the resource that best matches your goals....

ICON will be at #EBF, 18–20 November. Visit booth B-15 to meet our bioanalytical experts and learn how we support drug development with regulatory-compliant solutions. https://ow.ly/1ECG50XiU3s

Antibody-drug conjugates (ADCs) are transforming cancer treatment — but measuring free payload concentrations is critical to ensure their safety and efficacy. Even the smallest impurity can skew results. Discover how adv...